Montefiore Einstein is part of a consortium of academic medical centers examining factors related to the occurrence of thrombolysis in myocardial infarction (TIMI) during the treatment of unstable ischemic events. This national multicenter trial examines the effectiveness of a novel thienopyridine agent in patients with acute coronary syndromes.
